[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

HealthTree Research

Our HealthTree Research events help you learn about the latest research and studies related to your cancer, including interviews with medical specialists.

Popular All Categories Navigating Your HealthTreatment & TestingFinancial AssistanceQ&AHealthTree ResearchCommunity DaysHealthTree RoundtablesSupport
Upcoming Events Past Events
Menin Inhibitors 101 with Dr. Joshua Zeidner image
Menin Inhibitors 101 with Dr. Joshua Zeidner

Jul 09, 2024

Adult AML Chapter

podcasts
HealthTree Cure Tour Workshop: Salt Lake City (In-Person) with Dr. Douglas Sborov image
HealthTree Cure Tour Workshop: Salt Lake City (In-Person) with Dr. Douglas Sborov

Jul 02, 2024

HealthTree Foundation for Multiple Myeloma

Virtual HealthTree Cure Tour Workshop With Our Founder & CEO Jenny Ahlstrom image
Virtual HealthTree Cure Tour Workshop With Our Founder & CEO Jenny Ahlstrom

Jun 26, 2024

HealthTree Foundation for Multiple Myeloma

smart_display
HealthTree Cure Tour Workshop: Columbus (In-Person) with Francesca Cottini, MD image
HealthTree Cure Tour Workshop: Columbus (In-Person) with Francesca Cottini, MD

Jun 08, 2024

HealthTree Foundation for Multiple Myeloma

HealthTree Cure Tour: Houston (In-Person) with Dr. Krina Patel image
HealthTree Cure Tour: Houston (In-Person) with Dr. Krina Patel

May 09, 2024

HealthTree Foundation for Multiple Myeloma

HealthTree Cure Tour: Dallas (In-Person) with Dr. Gurbakhash Kaur image
HealthTree Cure Tour: Dallas (In-Person) with Dr. Gurbakhash Kaur

May 07, 2024

HealthTree Foundation for Multiple Myeloma

HealthTree Cure Tour: Syracuse, NY (In-Person) with Drs. Malek and Ghimire image
HealthTree Cure Tour: Syracuse, NY (In-Person) with Drs. Malek and Ghimire

May 02, 2024

HealthTree Foundation for Multiple Myeloma

Reducing Relapse Risk After Transplant Using Jakafi With Gabriela Hobbs, MD, Massachusetts General Hospital image
Reducing Relapse Risk After Transplant Using Jakafi With Gabriela Hobbs, MD, Massachusetts General Hospital

Oct 05, 2022

HealthTree Podcast for AML

podcasts
Expanding the Use of Ivosidenib (Tibsovo) In Newly Approved Combination For IDH1-Mutated AML with Eytan Stein, MD, Memorial Sloan Kettering image
Expanding the Use of Ivosidenib (Tibsovo) In Newly Approved Combination For IDH1-Mutated AML with Eytan Stein, MD, Memorial Sloan Kettering

Aug 24, 2022

HealthTree Podcast for AML

podcasts
Working to Overcome Health Disparities in AML image
Working to Overcome Health Disparities in AML

Mar 30, 2022

Adult AML Chapter

smart_display

Trending Articles

End-of-Life Care: Understanding Symptoms and AML Progression End-of-Life Care: Understanding Symptoms and AML Progression
New FDA-Designated Cell Therapy for AML, ALL, and MDS New FDA-Designated Cell Therapy for AML, ALL, and MDS
The FDA Is Reviewing A New Treatment Option For Relapsed/Refractory AML The FDA Is Reviewing A New Treatment Option For Relapsed/Refractory AML
EHA 2024: Patient Outcomes from Oral Azacitidine Maintenance Therapy EHA 2024: Patient Outcomes from Oral Azacitidine Maintenance Therapy
What Are The AML Types, and How Are They Classified? What Are The AML Types, and How Are They Classified?

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube

Charity Navigator https://www.guidestar.org/profile/45-5354811

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2024 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811